Sodium-glucose cotransporter-2 inhibitors and risk of incident kidney disease in patients with gout
Objectives This study aimed to compare the risk of kidney outcomes in patients with gout and type 2 diabetes (T2D) who used sodium-glucose cotransporter-2 inhibitors (SGLT2i) and those who did not. Methods Using the TriNetX US Collaborative Network, we conducted a retrospective cohort study comparing patients with gout and type 2 diabetes who initiated SGLT2i or dipeptidyl peptidase-4 inhibitors (DPP-4i). After 1:1 propensity score matching, 2,676 pairs were included in the primary active-comparator analysis. Kidney outcomes, hospitalization, and all-cause mortality were evaluated using Cox proportional hazards models. A comparison between SGLT2i users and nonusers was retained as a secondary analysis. Results In the primary analysis, SGLT2i initiation was associated with lower risks of composite kidney outcomes (HR, 0.848; 95% CI, 0.775–0.929), incident CKD (HR, 0.851; 95% CI, 0.777–0.932), and all-cause mortality (HR, 0.702; 95% CI, 0.571–0.864) compared with DPP-4i initiation. No statistically significant differences were observed in dialysis or kidney transplantation (HR, 0.685; 95% CI, 0.388–1.210) or all-cause hospitalization (HR, 0.941; 95% CI, 0.857–1.032). Findings from the secondary SGLT2i versus non-SGLT2i analysis were generally consistent. Conclusion Our study found that SGLT2i use in patients with gout and T2D was associated with a lower risk of developing CKD, and all-cause mortality, compared to those not using SGLT2i.
Authors
- Fu‐Shun Yen (ORCID: https://orcid.org/0000-0002-4677-2415)
- Chii‐Min Hwu (ORCID: https://orcid.org/0000-0002-8209-9627)
- Yao‐Min Hung (ORCID: https://orcid.org/0000-0001-6920-8799)
- James Cheng-Chung Wei
- Chih‐Cheng Hsu
- Jing-Yang Huang
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Health Research Institutes (TW)
- China Medical University (TW)
- Min Sheng General Hospital (TW)
- Taipei Veterans General Hospital (TW)
- Chung Shan Medical University Hospital (TW)
- Kaohsiung Veterans General Hospital (TW)
- Chung Shan Medical University (TW)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fphar.2026.1998539
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00